Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets
Crossref DOI link: https://doi.org/10.1186/s13046-021-01968-w
Published Online: 2021-05-18
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Luo, Xiang-Yuan
Wu, Kong-Ming
He, Xing-Xing http://orcid.org/0000-0003-0001-8473
Text and Data Mining valid from 2021-05-18
Version of Record valid from 2021-05-18
Article History
Received: 9 February 2021
Accepted: 27 April 2021
First Online: 18 May 2021
Declarations
:
: Not applicable.
: The authors declare that they have no competing interests.